Lilly announces new study data on Inluriyo in metastatic breast cancer
The five-year survival rate for metastatic breast cancer is 30%
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Lilly announces new study data on Inluriyo in metastatic breast cancer
The five-year survival rate for metastatic breast cancer is 30%
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
AstraZeneca’s Enhertu combination approved by FDA for HER2-positive breast cancer
Around one in five breast cancer cases are HER2-positive
Lilly announces plans for $6bn US manufacture facility
The site is the third of four new US sites that Lilly has announced
PMLiVE’s T40 2025 – results announced!
Find out which agencies came top and which agencies are among the big climbers in this year’s list
Latest content
Scaling AI in healthcare communications: from pilots to living systems
By Andreas Reinbolz and Thomas Nisters
Read More
Launch differently: how unforgettable brands break through
By Whitney Morley and Jo Crouch
Read More
Intelligence
The trust crisis: how pharma must evolve to engage Gen Z HCPs
Trust isn’t a campaign outcome; it’s the product of behaviour, language and consistency
Read More
Setting out – why omnichannel success is about orchestration
Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train
Read More
Global regulatory standards
The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness
Read More
Patient insight: human vs AIHCPS
If we’re using AI to inform healthcare decisions, ethical guard rails are essential
Read More
Bridging the affordability gap
How pharma can rebuild competitiveness from the factory floor
Read More
ESMO 2025 – ensuring innovation isn’t lost in translation
This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
Read More
Blogs
Latest
Lack of education causes patients to stop vital treatments, survey finds
December 15, 2025 | Healthinote (by Cognitant)|Cognitant, Whitepaper, medication adherence, patient education, research
Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit from prescribed treatments. Nearly …
Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview
December 11, 2025 | Genesis Research Group|
At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright’s HEOR Theater presentation ‘MFN Pricing: More Fun to Navigate – A European …
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
December 11, 2025 | Inizio|Pharmaphorum
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
Exhibition Trends 2026: What Pharma Exhibitors Need to Know Now
December 8, 2025 | Apex Events and Exhibitions|2026 trends, Exhibition Stand Design, Exhibition Stands, Pharma Events, Sustainability, exhibitions, inclusivity, pharma exhibitions, purposeful tech, technology
Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and build trust. Whether you’re launching innovations, strengthening …
Amiculum earns EcoVadis silver medal for the 3rd year running
December 5, 2025 | Amiculum|EcoVadis, Sustainability
We’re proud to announce that we have once again strengthened our commitment to sustainability! Our 2025 EcoVadis reassessment has resulted in a score of 75/100, …
What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends
December 16, 2025 | Amiculum|AI, JCA, Market Access, Patient-integrated Communications, VuuAI, genAI, healthcare communications, misinformation, omnichannel, trends
By Sarah Theobald
Clinical research in 2026: The trends shaping tomorrow
December 16, 2025 | Cuttsy + Cuttsy|Communications, Decentralised trials, Digital, Pharma, advocacy, clinical trials, partnerships, patient engagement
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
AI persona generation for healthcare: quick wins & real-world impact
December 4, 2025 | Amiculum|AI, Persona generation, Segmentation, artificial intelligence, healthcare communications, omnichannel
By Aaron Fletcher
From overwhelming to actionable: Bringing lifestyle guidance to life
December 2, 2025 | Cuttsy + Cuttsy|Inclusive design, communication, design, health literacy, patient engagement
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Behind the scenes: why we created ‘The participation equation’
November 28, 2025 | Cuttsy + Cuttsy|Insights, Patient first, The participation equation, clinical trials, patient engagement
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.